Salute e Benessere

SheMed Raises $50M to Scale Personalised Women's Health Services

The new funding will be used to expand SheMed's UK operations, scaling its medical and technology teams, strengthening clinical infrastructure and enhancing its data-driven capabilities. The investment will also support new research and patient-experience initiatives designed to improve access to high-quality, personalised care for women across the UK. The new funding will be used to expand SheMed's UK operations, scaling its medical and technology teams, strengthening clinical infrastructure...
PR Newswire
23/10/2025

Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for…

Glomerulonephritis Market Summary Glomerulonephritis Market Summary Discover the glomerulonephritis new treatment @New Treatments for Glomerulonephritis Key Factors Driving the Growth of the Glomerulonephritis Market Rising Incidence of Glomerulonephritis and Associated Conditions The increasing prevalence of autoimmune diseases, diabetes, hypertension, and infections such as post-streptococcal glomerulonephritis is contributing to a higher incidence of GN cases,...
PR Newswire
22/10/2025

Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5…

A replay of the webcast will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcast will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the...
PR Newswire
22/10/2025

Probiotic Market to Reach USD 280.37 Billion Globally by 2032, Growing At An…

The report, titled "Probiotic Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032," provides a granular view of the forces shaping this dynamic industry. Probiotics, defined as live microorganisms that confer a health benefit when consumed in adequate amounts, are at the forefront of the functional foods movement. Once primarily associated with yogurt, these beneficial bacteria are now integral components in dietary supplements, fermented beverages…
PR Newswire
22/10/2025

BASTIDE : 2024-2025 annual results in line with targets // 2025-26 outlook…

Caissargues, October 22, 2025 – Groupe Bastide, a leading European provider of home healthcare services, has announced its 2024-2025 annual results at June 30, 2025. The 2024-2025 annual consolidated financial statements were approved by the Board of Directors at its meeting on October 21, 2025. The Statutory Auditors have audited the financial…
Actusnews Wire
22/10/2025

RealMan and Ossum by Vini International Set Guinness World Record™ in Dubai

Participants were seated in a specially cordoned area within the Trade Centre hall. At the orchestrated signal, they applied their chosen RealMan or Ossum fragrance in perfect unison, generating an electric, high-energy atmosphere. Television and social media cameras captured every angle, while Mithun Ramesh anchored the proceedings. The stunt served as the centerpiece of VINI INTERNATIONAL's wider campaign to spotlight both brands. Participants were seated in a specially cordoned area within...
PR Newswire
22/10/2025

ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)Private placement is expected to be anchored by multiple...
Nasdaq GlobeNewswire
22/10/2025

SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the…

"This study represents a major step forward in evaluating personalized melanoma care," said Vernon Sondak, MD, MERLIN_001 Principal Investigator and chair of the Cutaneous Oncology Department at Moffitt Cancer Center in Tampa, Florida. "Studying the Merlin CP-GEP Test's ability to distinguish patients' risk of sentinel node metastasis with a rigor and precision no other test or nomogram can match. Our results show that the test adds a level of accuracy above current clinical…
PR Newswire
22/10/2025

CathWorks Announces Key Events for TCT 2025

The CathWorks FFRangio® System will be featured in multiple abstracts and scientific presentations, live cases and an academic satellite program with an all-star faculty. The CathWorks booth will feature hands-on demonstrations with the latest FFRangio technology and peer-to-peer best practice sharing during Expert Exchange sessions hosted by leading physicians. The CathWorks FFRangio ®System will be featured in multiple abstracts and scientific presentations, live cases and an academic...
PR Newswire
22/10/2025

US Premium Beauty and Personal Care Market Eyes USD 56.47 Billion by 2032 |…

The US Premium Beauty and Personal Care Market, valued at approximately USD 49.25 billion in 2025, is anticipated to witness steady growth, reaching an estimated USD 56.47 billion by 2032. This growth represents a compound annual growth rate (CAGR) of around 1.97% from 2026 to 2032. Key drivers include an increasing consumer demand for personalized skincare where science-backed products lead the market, alongside a growing emphasis on sustainability and clean beauty formulations. As American…
PR Newswire
22/10/2025

NOTICE OF MAKE WHOLE REDEMPTION PRICE

MAXIMA GRUPE, UAB (the "Issuer") 1 €240,000,000 6.250 per cent. Notes due 2027 (the "Notes")(ISIN: XS2485155464) (Common Code: 248515546) 22 October 2025We refer to the terms and conditions of the Notes (the " Conditions ") and the notice (the " Initial Notice ") of the Issuer dated 10 October 2025 relating to the early redemption of the Notes on 27 October 2025 (the " Make Whole Optional Redemption Date ") at the Make Whole Redemption Price…
Nasdaq GlobeNewswire
22/10/2025

Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery…

Nasir Khan, DVM, Ph.D.: Senior Vice President of Preclinical Development Gary Ingenito, MD, Ph.D.: Senior Vice President of Clinical Development WALTHAM, Mass., Oct.22, 2025(GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative therapies for age-related degenerative diseases, today announced the appointment of Nasir Khan, DVM, Ph.D., as Senior Vice President of Preclinical Development, effective October 20,...
Nasdaq GlobeNewswire
22/10/2025

EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra…

sHLH is a severe and life-threatening inflammatory condition triggered by underlying diseases such as cancer, autoimmune disorders, or serious infections. It causes the immune system to go into overdrive, leading to widespread inflammation and organ failure. There are currently no FDA-approved treatments for sHLH broadly, and in cancer-associated sHLH, survival at 8 weeks is only about 50 percent with existing options. Electra's ELA026 is an antibody targeting Signal Regulatory Proteins (SIRP)…
PR Newswire
22/10/2025

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex…

Appointment reinforces ProMIS Neurosciences’ strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer’s program, PMN310 Cambridge, Massachusetts, Oct.22, 2025(GLOBE NEWSWIRE) --ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that Slanix Paul Alex, Pharm.D., President and Portfolio Manager...
Nasdaq GlobeNewswire
22/10/2025

Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol…

Dapirolizumab pegol (DZP) Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease activity/remission, flares, fatigue, joint pain and quality of lifePresentation of preclinical study of DZP showing minimal to no human placental transfer CAMBRIDGE, Mass., Oct.22, 2025(GLOBE NEWSWIRE) --Biogen Inc. (Nasdaq: BIIB) today announced upcoming presentations from studies evaluating dapirolizumab pegol (DZP), a novel Fc-free...
Nasdaq GlobeNewswire
22/10/2025

Gummy Supplement Market worth $47.79 billion by 2030- Exclusive Report by…

The expansion of e-commerce and pharmacy distribution channels enhances accessibility, while strategic marketing and personalized wellness trends contribute to sustained consumer engagement. Regulatory compliance, ensuring product safety and quality, also boosts market confidence. The interplay of convenience, innovation, and evolving lifestyle preferences constitutes the key drivers behind the robust growth of the gummy supplements market. The expansion of e-commerce and pharmacy…
PR Newswire
22/10/2025

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac…

Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next milestone in the execution of its oncology strategyCureVac shareholders receive approximately $5.46 in BioNTech American Depositary Shares for each CureVac share, subject to a collar; an indicative exchange ratio will be available at www.envisionreports.com/CureVacOfferfor the duration of the exchange offer...
Nasdaq GlobeNewswire
22/10/2025

JASCAYD® (nerandomilast) approved in China for the treatment of idiopathic…

Approval is based on results from Phase III FIBRONEER™-IPF trial, which showed statistically significant improvements in the absolute change from baseline in Forced Vital Capacity at 52 weeks with nerandomilast 18 mg and 9 mg versus placebo in adults with idiopathic pulmonary fibrosis (IPF) 1,2 Nerandomilast was included in the priority review by the Centre for Drug Evaluation (CDE) of the NMPA in January this year, and was recently granted FDA approval in the United States....
Nasdaq GlobeNewswire
22/10/2025

Cambrex Unveils $120 Million Investment to Expand API Manufacturing and…

The $120 million investment will support a 40% increase in the Charles City, Iowa site's large-scale manufacturing capacity, reaching nearly one million liters. The Charles City facility, situated on a 45-acre site, manufactures a broad range of APIs and pharmaceutical intermediates, including highly potent molecules and controlled substances. The$120 millioninvestment will support a 40% increase in theCharles City, Iowasite's large-scale manufacturing capacity, reaching nearly one million…
PR Newswire
22/10/2025

Oticon announces world's first hearing aids with Google's Fast Pair: Oticon…

"We are immensely proud to bring Google's Fast Pair to our LE Audio hearing aids. Oticon Intent and Oticon Zeal are the world's first hearing aids to offer Google Fast Pair, a testament to our strong collaboration with Google. Together, we have pioneered the most effortless way to connect Oticon LE Audio hearing aids to Android LE Audio devices, setting a new standard for accessibility, to the benefit of millions of hearing aid users across the globe," says Frederik Gundelach, Senior…
PR Newswire
22/10/2025

Europe Leads Dental Implants Market Growth to 2030 with Zirconia Implants…

Geographic Segment Insights Geographic Segment Insights Europecontinues to dominate the dental implant landscape, supported by strong clinical expertise, high patient spending power, and an established training ecosystem. Growing emphasis on long-term implant maintenance has encouraged manufacturers to integrate follow-up solutions into their product offerings, strengthening brand loyalty among dental professionals. InAsia-Pacific, the market is expanding rapidly as rising dental...
PR Newswire
22/10/2025

/C O R R E C T I O N -- Taiwan Institute of Economic Research/

FRANKFURT, Germany, Oct. 22, 2025 /PRNewswire/ -- Taiwan's healthcare system, ranked No. 1 worldwide in CEOWORLD Magazine's 2024 Health Care Index, is built on the integration of modern medicine with proven Traditional Chinese Medicine (TCM). At CPHI Frankfurt 2025, organized by Taiwan Institute of Economic Research, the Taiwan Traditional Chinese Medicine Pavilion (stand 12.1 C112) will highlight how Taiwan combines scientific validation with centuries of herbal wisdom to create innovative…
PR Newswire
22/10/2025

Industry-Leading Vinyl Range Sets New Standard in Glue-Down Flooring

Why this range stands out: Why this range stands out: "This collection reflects what our customers are looking for, flooring that performs exceptionally well, looks fantastic, and keeps things simple," Richard, Director of Flooring365.co.uk shared. "We're proud to offer one of the most comprehensive glue-down vinyl ranges on the market." The launch marks a major step forward in Flooring365.co.uk's mission to deliver exceptional flooring at accessible prices. With an unmatched…
PR Newswire
22/10/2025

Alvotech Announces Changes in Global Business Development and Commercial…

REYKJAVIK, ICELAND (OCTOBER 21, 2025)— Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced changes to its global business development and commercial operations team. Anil Okay, Chief Commercial Officer, is stepping down to serve as Chief Executive Officer of Adalvo. Trisha Durant has joined Alvotech as Senior Vice President, Global Business Development and Commercial Operation,...
Nasdaq GlobeNewswire
22/10/2025
Altri  Comunicati